Pre-transplantation specification of stem cells to cardiac lineage for regeneration of cardiac tissue

Stem Cell Reviews and Reports

Volumn 5, Issue 1, 2009, Pages 51-60

  Mayorga, Maritza ^a   Finan, Amanda ^a,b   Penn, Marc ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Cardiac differentiation; Cardiac tissue recovery; In vitro lineage specification; Mesenchymal stem cells; Myocardium infarct; Stem cells

Indexed keywords

BIOLOGICAL MODEL; CELL DIFFERENTIATION; CELL LINEAGE; CLINICAL TRIAL; CYTOLOGY; EMBRYONIC STEM CELL; HEART; HEART FAILURE; HEART INFARCTION; HEART MUSCLE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; MUSCLE CELL; PATHOLOGY; PHYSIOLOGY; REGENERATION; REVIEW; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

CELL DIFFERENTIATION; CELL LINEAGE; CLINICAL TRIALS AS TOPIC; EMBRYONIC STEM CELLS; HEART; HEART FAILURE; HUMANS; MODELS, BIOLOGICAL; MUSCLE CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; REGENERATION; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 70349252352     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-009-9050-8     Document Type: Article

References (118)

1. Lai, Z. F., Chen, Y. Z., Feng, L. P., et al. (2008). Overexpression of TNNI3K, a cardiac-specific MAP kinase, promotes P19CL6-derived cardiac myogenesis and prevents myocardial infarction-induced injury. American Journal of Physiology. Heart and Circulatory Physiology, 295(2), H708-716. doi:10.1152/ajpheart.00252.2008.
2. Rajasingh, J., Bord, E., Hamada, H., et al. (2007). STAT3-dependent mouse embryonic stem cell differentiation into cardiomyocytes: analysis of molecular signaling and therapeutic efficacy of cardiomyocyte precommitted mES transplantation in a mouse model of myocardial infarction. Circulation Research, 101(9), 910-918. doi:10.1161/CIRCRESAHA.107.156786.
3. Laflamme, M. A., Chen, K. Y., Naumova, A. V., et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology, 25(9), 1015-1024. doi:10.1038/nbt1327.
4. Tomescot, A., Leschik, J., Bellamy, V., et al. (2007). Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. Stem Cells, 25(9), 2200-2205. doi:10.1634/stemcells.2007-0133.
5. Behfar, A., Perez-Terzic, C., Faustino, R. S., et al. (2007). Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. Journal of Experimental Medicine, 204(2), 405-420. doi:10.1084/jem.20061916.
6. Kofidis, T., Lebl, D. R., Swijnenburg, R. J., Greeve, J. M., Klima, U., & Robbins, R. C. (2006). Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury. European Journal of Cardio-thoracic Surgery, 29(1), 50-55. doi:10.1016/j.ejcts.2005.10.015.
7. Menard, C., Hagege, A. A., Agbulut, O., et al. (2005). Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet, 366(9490), 1005-1012. doi:10.1016/S0140-6736(05)67380-1.
8. Kofidis, T., de Bruin, J. L., Yamane, T., et al. (2005). Stimulation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and host-specific differentiation in the heart after ischemic myocardial injury. Circulation, 111(19), 2486-2493. doi:10.1161/01.CIR.0000165063.09283.A8.
9. Kofidis, T., de Bruin, J. L., Yamane, T., et al. (2004). Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells, 22(7), 1239-1245. doi:10.1634/stemcells.2004-0127.
10. Mazo, M., Planat-Benard, V., Abizanda, G., et al. (2008). Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction. European Journal of Heart Failure, 10(5), 454-462. doi:10.1016/j.ejheart.2008.03.017.
11. Hahn, J. Y., Cho, H. J., Kang, H. J., et al. (2008). Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. Journal of the American College of Cardiology, 51(9), 933-943. doi:10.1016/j.jacc.2007.11.040.
12. Grauss, R. W., van, T. J., Steendijk, P., et al. (2008). Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts. Stem Cells, 26(4), 1083-1093. doi:10.1634/stemcells.2007-0523.
13. Plotnikov, A. N., Shlapakova, I., Szabolcs, M. J., et al. (2007). Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation, 116(7), 706-713. doi:10.1161/CIRCULATIONAHA.107.703231.
14. Markel, T. A., Crisostomo, P. R., Manukyan, M. C., et al. (2008). Are Neonatal Stem Cells as Effective as Adult Stem Cells in Providing Ischemic Protection? Journal of surgical research, April 28.
15. Schierling, W., Kunz-Schughart, L. A., Muders, F., Riegger, G. A., & Griese, D. P. (2008). Fates of genetically engineered haematopoietic and mesenchymal stem cell grafts in normal and injured rat hearts. Journal of Tissue Engineering and Regenerative Medicine, 2(6), 354-364. doi:10.1002/term.104.
16. Kruglyakov, P. V., Sokolova, I. B., Zin'kova, N. N., et al. (2006). In vitro and in vivo differentiation of mesenchymal stem cells in the cardiomyocyte direction. Bulletin of Experimental Biology and Medicine, 142(4), 503-506. doi:10.1007/s10517-006-0403-x.
17. Ventura, C., Cantoni, S., Bianchi, F., et al. (2007). Hyaluronan mixed esters of butyric and retinoic Acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts. The Journal of Biological Chemistry, 282(19), 14243-14252. doi:10.1074/jbc.M609350200.
18. Shiota, M., Heike, T., Haruyama, M., et al. (2007). Isolation and characterization of bone marrow-derived mesenchymal progenitor cells with myogenic and neuronal properties. Experimental Cell Research, 313(5), 1008-1023. doi:10.1016/j.yexcr.2006.12.017.
19. Tomita, Y., Makino, S., Hakuno, D., et al. (2007). Application of mesenchymal stem cell-derived cardiomyocytes as bio-pacemakers: current status and problems to be solved. Medical and Biological Engineering Computing, 45(2), 209-220. doi:10.1007/s11517-007-0163-4.
20. Martin, G. R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proceedings of the National Academy of Sciences of the United States of America, 78(12), 7634-7638. doi:10.1073/pnas.78.12.7634.
21. Bartunek, J., Croissant, J. D., Wijns, W., et al. (2007). Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. American Journal of Physiology. Heart and Circulatory Physiology, 292(2), H1095-1104. doi:10.1152/ajpheart.01009.2005.
22. Itskovitz-Eldor, J., Schuldiner, M., Karsenti, D., et al. (2000). Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Molecular Medicine, 6(2), 88-95.
23. Yau, T. M., Li, G., Zhang, Y., Weisel, R. D., Mickle, D. A., & Li, R. K. (2005). Vascular endothelial growth factor receptor upregulation in response to cell-based angiogenic gene therapy. Annals of Thoracic Surgery, 79(6), 2056-2063. doi:10.1016/j.athoracsur.2004.10.066.
24. Li, T. S., Hayashi, M., Ito, H., et al. (2005). Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells. Circulation, 111(19), 2438-2445. doi:10.1161/01.CIR.0000167553.49133.81.
25. Hombach-Klonisch, S., Panigrahi, S., Rashedi, I. et al. (2008). Adult stem cells and their trans-differentiation potential-perspectives and therapeutic applications. Journal of Molecular Medicine, July 16.
26. Baksh, D., Song, L., & Tuan, R. S. (2004). Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. Journal of Cellular and Molecular Medicine, 8(3), 301-316. doi:10.1111/j.1582-4934.2004.tb00320.x.
27. Laugwitz, K. L., Moretti, A., Lam, J., et al. (2005). Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature, 433(7026), 647-653. doi:10.1038/nature03215.
28. Oh, H., Bradfute, S. B., Gallardo, T. D., et al. (2003). Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proceedings of the National Academy of Sciences of the United States of America, 100(21), 12313-12318. doi:10.1073/pnas.2132126100.
29. Mouquet, F., Pfister, O., Jain, M., et al. (2005). Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circulation Research, 97(11), 1090-1092. doi:10.1161/01.RES.0000194330.66545.f5.
30. Kale, S., Karihaloo, A., Clark, P. R., Kashgarian, M., Krause, D. S., & Cantley, L. G. (2003). Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. European Journal of Clinical Investigation, 112(1), 42-49.
31. Unzek, S., Zhang, M., Mal, N., Mills, W. R., Laurita, K. R., & Penn, M. S. (2007). SDF-1 recruits cardiac stem cell like cells that depolarize in vivo. Cell Transplant, 16, 879-886. doi:10.3727/096368907783338271.
32. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663-676. doi:10.1016/j.cell.2006.07.024.
33. Blelloch, R., Venere, M., Yen, J., & Ramalho-Santos, M. (20007). Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell, 1(3), 245-247. doi:10.1016/j.stem.2007.08.008.
34. Okita, K., Ichisaka, T., & Yamanaka, S. (2007). Generation of germline-competent induced pluripotent stem cells. Nature, 448(7151), 313-317. doi:10.1038/nature05934.
35. Wernig, M., Meissner, A., Foreman, R., et al. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature, 448(7151), 318-324. doi:10.1038/nature05944.
36. Nishikawa, S., Goldstein, R. A., & Nierras, C. R. (2008). The promise of human induced pluripotent stem cells for research and therapy. Nature Reviews. Molecular Cell Biology, 9(9), 725-729. doi:10.1038/nrm2466.
37. Mathe, G., Amiel, J. L., Schwarzenberg, L., Cattan, A., & Schneider, M. (1963). Haematopoietic chimera in man after allogeneic bone-marrow transplantation. British Medical Journal, 2(5373), 1633-1635.
38. Tateishi, K., Takehara, N., Matsubara, H., Oh, H. (2008). Stemming heart failure with cardiac- or reprogrammed-stem cells. Journal of Cellular and Molecular Medicine, August 27.
39. Segers, V. F., & Lee, R. T. (2008). Stem-cell therapy for cardiac disease. Nature, 451(7181), 937-942. doi:10.1038/nature06800.
40. Murry, C. E., Soonpaa, M. H., Reinecke, H., et al. (2004). Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature, 428(6983), 664-668. doi:10.1038/nature02446.
41. Balsam, L. B., Wagers, A. J., Christensen, J. L., Kofidis, T., Weissman, I. L., & Robbins, R. C. (2004). Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature, 428(6983), 668-673. doi:10.1038/nature02460.
42. Zhang, M., Mal, N., kiedrowski, M., et al. (2007). SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes following myocardial infarction. FASEB journal, 21, 3197-3207. doi:10.1096/fj.06-6558com.
43. Charwat, S., Gyongyosi, M., Lang, I., et al. (2008). Role of adult bone marrow stem cells in the repair of ischemic myocardium: current state of the art. Experimental hematology, 36(6), 672-680. doi:10.1016/j.exphem.2008.01.005.
44. Losordo, D. W., Schatz, R. A., White, C. J., et al. (2007). Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation, 115(25), 3165-3172. doi:10.1161/CIRCULATIONAHA.106.687376.
45. Meluzin, J., Janousek, S., Mayer, J., et al. (2008). Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. International journal of cardiology, 128(2), 185-192. doi:10.1016/j.ijcard.2007.04.098.
46. Assmus, B., Schachinger, V., Teupe, C., et al. (2002). Transplantation of progenitor cells cand regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation, 106(24), 3009-3017. doi:10.1161/01.CIR.0000043246.74879.CD.
47. bdel-Latif, A., Bolli, R., Tleyjeh, I. M., et al. (2007). Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Archives of internal medicine, 167(10), 989-997 May 28.
48. Wollert, K. C., Meyer, G. P., Lotz, J., et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 364(9429), 141-148. doi:10.1016/S0140-6736(04)16626-9.
49. Chen, S. L., Fang, W. W., Ye, F., et al. (2004). Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. American journal of cardiology, 94(1), 92-95. doi:10.1016/j.amjcard.2004.03.034.
50. Lunde, K., Solheim, S., Aakhus, S., et al. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. New England journal of medicine, 355(12), 1199-1209. doi:10.1056/NEJMoa055706.
51. Schachinger, V., Erbs, S., Elsasser, A., et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. New England journal of medicine, 355(12), 1210-1221. doi:10.1056/NEJMoa060186.
52. Tse, H. F., Kwong, Y. L., Chan, J. K., Lo, G., Ho, C. L., & Lau, C. P. (2003). Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet, 361(9351), 47-49. doi:10.1016/S0140-6736(03)12111-3.
53. Perin, E. C., Dohmann, H. F., Borojevic, R. et al. (2003). Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure. Circulation, April 21.
54. Beeres, S. L., Bax, J. J., bbets-Schneider, P., et al. (2006). Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: 12-month follow-up results. American heart journal, 152(4), 684-686. doi:10.1016/j.ahj.2006.07.018.
55. Penn, M. S., & Khalil, M. K. (2008). Exploitation of stem cell homing for gene delivery. Expert Opinion on Biological Therapy, 8(1), 17-30. doi:10.1517/14712598.8.1.17.
56. Deglurkar, I., Mal, N., Mills, W. R., et al. (2006). Mechanical and electrical effects of cell-based gene therapy for ischemic cardiomyopathy are independent. Human gene therapy, 17(11), 1144-1151. doi:10.1089/hum.2006.17.1144.
57. Askari, A., Unzek, S., Popovic, Z. B., et al. (2003). Effect of stromal-cell-derived factor-1 on stem cell homing and tissue regeneration in ischemic cardiomyopathy. Lancet, 362, 697-703. doi:10.1016/S0140-6736(03)14232-8.
58. Assmus, B., Honold, J., Schachinger, V., et al. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. New England journal of medicine, 355(12), 1222-1232. doi:10.1056/NEJMoa051779.
59. Janssens, S., Dubois, C., Bogaert, J., et al. (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet, 367(9505), 113-121. doi:10.1016/S0140-6736(05)67861-0.
60. Penn, M. S. (2006). Stem-cell therapy after acute myocardial infarction: the focus should be on those at risk. Lancet, 367(9505), 87-88. doi:10.1016/S0140-6736(05)67895-6.
61. Yamahara, K., & Nagaya, N. (2008). Stem cell implantation for myocardial disorders. Current Drug Delivery, 5(3), 224-229. doi:10.2174/156720108784911703.
62. Cogle, C. R., Madlambayan, G. J., Hubsher, G., et al. (2008). Marrow cell therapies for cardiovascular diseases. Experimental hematology, 36(6), 687-694. doi:10.1016/j.exphem.2008.01.012.
63. Dimmeler, S., Burchfield, J., & Zeiher, A. M. (2008). Cell-based therapy of myocardial infarction. Arterioscler Thromb Vascular Biology, 28(2), 208-216. doi:10.1161/ATVBAHA.107.155317.
64. Pelacho, B., Nakamura, Y., Zhang, J., et al. (2007). Multipotent adult progenitor cell transplantation increases vascularity and improves left ventricular function after myocardial infarction. Journal of Tissue Engineering and Regenerative Medicine, 1(1), 51-59. doi:10.1002/term.7.
65. Van't, H. W., Mal, N., Huang, Y., et al. (2007). Direct delivery of syngeneic and allogeneic large-scale expanded multipotent adult progenitor cells improves cardiac function after myocardial infarct. Cytotherapy, 9(5), 477-487. doi:10.1080/14653240701452065.
66. Leor, J., Guetta, E., Feinberg, M. S., et al. (2006). Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium. Stem cells, 24(3), 772-780. doi:10.1634/stemcells.2005-0212.
67. Klug, M. G., Soonpaa, M. H., Koh, G. Y., & Field, L. J. (1996). Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. Journal of clinical investigation, 98(1), 216-224. doi:10.1172/JCI118769.
68. Muller, M., Fleischmann, B. K., Selbert, S., et al. (2000). Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB Journal, 14(15), 2540-2548. doi:10.1096/fj.00-0002com.
69. Huber, I., Itzhaki, I., Caspi, O., et al. (2007). Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB Journal, 21(10), 2551-2563. doi:10.1096/fj.05-5711com.
70. Mauritz, C., Schwanke, K., Reppel, M., et al. (2008). Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation, 118(5), 507-517. doi:10.1161/CIRCULATIONAHA.108.778795.
71. Narazaki, G., Uosaki, H., Teranishi, M., et al. (2008). Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation, 118(5), 498-506. doi:10.1161/CIRCULATIONAHA.108.769562.
72. Koh, G. Y., Soonpaa, M. H., Klug, M. G., et al. (1995). Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. Journal of clinical investigation, 96(4), 2034-2042. doi:10.1172/JCI118251.
73. Koh, G. Y., Soonpaa, M. H., Klug, M. G., & Field, L. J. (1993). Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium. American journal of physiology, 264, H1727-1733 (5 Pt 2).
74. Matsushita, T., Oyamada, M., Kurata, H., et al. (1999). Formation of cell junctions between grafted and host cardiomyocytes at the border zone of rat myocardial infarction. Circulation, 100(Suppl 19), II262-8.
75. Li, R. K., Mickle, D. A., Weisel, R. D., et al. (1997). Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation, 96(Suppl l9), II-86.
76. Hodgson, D. M., Behfar, A., Zingman, L. V., et al. (2004). Stable benefit of embryonic stem cell therapy in myocardial infarction. American Journal of Physiology Heart and Circulatory Physiology, 287(2), H471-479. doi:10.1152/ajpheart.01247.2003.
77. Mills, W. R., Mal, N., Forudi, F., Popovic, Z. B., Penn, M. S., & laurita, K. R. (2006). Optical mapping of late myocardial infarction in rats. American Journal of Physiology Heart and Circulatory Physiology, 290(3), H1298-1306. doi:10.1152/ajpheart.00437.2005.
78. Mills, W. R., Mal, N., Kiedrowski, M. J., et al. (2007). Stem cell therapy enhances electrical viability in myocardial infarction. Journal of Molecular and Cellular Cardiology, 42(304), 314.
79. Faustino, R. S., Behfar, A., Perez-Terzic, C., & Terzic, A. (2008). Genomic chart guiding embryonic stem cell cardiopoiesis. Genome Biology, 9(1), R6. doi:10.1186/gb-2008-9-1-r6.
80. Arrell, D. K., Niederlander, N. J., Faustino, R. S., Behfar, A., & Terzic, A. (2008). Cardioinductive network guiding stem cell differentiation revealed by proteomic cartography of tumor necrosis factor alpha-primed endodermal secretome. Stem Cells, 26(2), 387-400. doi:10.1634/stemcells.2007-0599.
81. Penn, M. S. (2007). Cell-based gene tcherapy for the prevention and treatment of cardiac dysfunction. Nature Clinical Practice Cardiovascular Medicine, 4(Suppl 1), S83-88. doi:10.1038/ncpcardio0733.
82. Penn, M. S., & Mangi, A. A. (2008). Genetic enhancement of stem cell engraftment, survival, and efficacy. Circulation research, 102(12), 1471-1482. doi:10.1161/CIRCRESAHA.108.175174.
83. Hahn, J. Y., Cho, H. J., Kang, H. J., et al. (2008). Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. Journal of the American College of Cardiology, 51(9), 933-943. doi:10.1016/j.jacc.2007.11.040.
84. Ivey, K. N., Muth, A., Arnold, J., et al. (2008). MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell, 2(3), 219-229. doi:10.1016/j.stem.2008.01.016.
85. Bian, J., Popovic, Z. B., Benejam, C., kiedrowski, M., Rodriguez, L. L., & Penn, M. S. (2007). Effect of cell-based intercellular delivery of transcription factor GATA4 on ischemic cardiomyopathy. Circulation research, 100(11), 1626-1633. doi:10.1161/01.RES.0000269778.75877.68.
86. Kehat, I., Kenyagin-Karsenti, D., Snir, M., et al. (2001). Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. Journal of clinical investigation, 108(3), 407-414.
87. Capi, O., & Gepstein, L. (2006). Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes. Journal Control Release, 116(2), 211-218. doi:10.1016/j.jconrel.2006.06.027.
88. Laflamme, M. A., Gold, J., Xu, C., et al. (2005). Formation of human myocardium in the rat heart from human embryonic stem cells. American journal of pathology, 167(3), 663-671.
89. Yang, Y., Min, J. Y., Rana, J. S., et al. (2002). VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. Journal of applied physiology, 93(3), 1140-1151.
90. Kehat, I., Khimovich, L., Caspi, O., et al. (2004). Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nature biotechnology, 22(10), 1282-1289. doi:10.1038/nbt1014.
91. Swijnenburg, R. J., Schrepfer, S., Govaert, J. A., et al. (2008). Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proceedings of the National Academy of Sciences of the United States of America, 105(35), 12991-12996. doi:10.1073/pnas.0805802105.
92. Skerjanc, I. S., Petropoulos, H., Ridgeway, A. G., & Wilton, S. (1998). Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cells. Journal of biological chemistry, 273(52), 34904-34910. doi:10.1074/jbc.273.52.34904.
93. David, R., Brenner, C., Stieber, J., et al. (2008). MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling. Nature cell biology, 10(3), 338-345. doi:10.1038/ncb1696.
94. Grepin, C., Nemer, G., & Nemer, M. (1997). Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor. Development, 124(12), 2387-2395.
95. Wobus, A. M., Kaomei, G., Shan, J., et al. (1997). Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. Journal of Molecular and Cellular Cardiology, 29(6), 1525-1539. doi:10.1006/jmcc.1997.0433.
96. Ohnishi, S., Ohgushi, H., Kitamura, S., & Nagaya, N. (2007). Mesenchymal stem cells for the treatment of heart failure. International journal of hematology, 86(1), 17-21. doi:10.1532/IJH97.07041.
97. Liao, R., Pfister, O., Jain, M., & Mouquet, F. (2007). The bone marrow-cardiac axis of myocardial regeneration. Progress in cardiovascular diseases, 50(1), 18-30. doi:10.1016/j.pcad.2007.03.001.
98. Burt, R. K., Loh, Y., Pearce, W., et al. (2008). Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. Journal Of the American Medical Association, 299(8), 925-936. doi:10.1001/jama.299.8.925.
99. Porada, C. D., & Zanjani, E. D. (2006). meida-Porad G. Adult mesenchymal stem cells: a pluripotent population with multiple applications. Current stem cell research & therapy, 1(3), 365-369.
100. Li, X., Yu, X., Lin, Q., et al. (2007). Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. Journal of Molecular and Cellular Cardiology, 42(2), 295-303. doi:10.1016/j.yjmcc.2006.07.002.
101. Schenk, S., Mal, N., Finan, A., et al. (2007). Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells, 25(1), 245-251. doi:10.1634/stemcells.2006-0293.
102. Berry, M. F., Engler, A. J., Woo, Y. J., et al. (2006). Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. American Journal of Physiology Heart and Circulatory Physiology, 290(6), H2196-2203. doi:10.1152/ajpheart.01017.2005.
103. Makkar, R. R., Price, M. J., Lill, M., et al. (2005). Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. Journal of cardiovascular pharmacology and therapeutics, 10(4), 225-233. doi:10.1177/107424840501000403.
104. Shake, J. G., Gruber, P. J., Baumgartner, W. A., et al. (2002). Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Annals of thoracic surgery, 73(6), 1919-1925. doi:10.1016/S0003-4975(02)03517-8.
105. Nagaya, N., Kangawa, K., Itoh, T., et al. (2005). Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation, 112(8), 1128-1135. doi:10.1161/CIRCULATIONAHA.104.500447.
106. Dowell, J. D., Rubart, M., Pasumarthi, K. B., Soonpaa, M. H., & Field, L. J. (2003). Myocyte and myogenic stem cell transplantation in the heart. Cardiovascular Research, 58(2), 336-350. doi:10.1016/S0008-6363(03)00254-2.
107. Tomita, S., Li, R. K., Weisel, R. D., et al. (1999). Autologous transplantation of bone marrow cells improves damaged heart function. Circulation, 100(Suppl 19), II247-56.
108. Xu, C., Police, S., Rao, N., & Carpenter, M. K. (2002). Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circulation research, 91(6), 501-508. doi:10.1161/01.RES.0000035254.80718.91.
109. Wakitani, S., Saito, T., & Caplan, A. I. (1995). Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle and Nerve, 18(12), 1417-1426. doi:10.1002/mus.880181212.
110. Fukuda, K. (2003). Use of adult marrow mesenchymal stem cells for regeneration of cardiomyocytes. Bone Marrow Transplant, 32(Suppl 1), S25-27. doi:10.1038/sj.bmt.1703940.
111. Hakuno, D., Fukuda, K., Makino, S., et al. (2002). Bone marrow-derived regenerated cardiomyocytes (CMG Cells) express functional adrenergic and muscarinic receptors. Circulation, 105(3), 380-386. doi:10.1161/hc0302.102593.
112. Rangappa, S., Entwistle, J. W., Wechsler, A. S., & Kresh, J. Y. (2003). Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype. Journal of Thoracic and Cardiovascular Surgery, 126(1), 124-132. doi:10.1016/S0022-5223(03)00074-6.
113. Cihak, A. (1985). Effect of 5-azacytidine and its derivatives on gastric secretion. Pharmacology and Therapeutics, 28(1), 103-106. doi:10.1016/0163-7258(85)90084-1.
114. Burlacu, A. (2006). Can 5-azacytidine convert the adult stem cells into cardiomyocytes? A brief overview. Archives of physiology and biochemistry, 112(4-5), 260-264. doi:10.1080/13813450601094631.
115. Xiao, H., & Zhang, Y. Y. (2008). Understanding the role of transforming growth factor-beta signalling in the heart: overview of studies using genetic mouse models. Clinical and experimental pharmacology and physiology, 35(3), 335-341. doi:10.1111/j.1440-1681.2007.04876.x.
116. Lim, J. Y., Kim, W. H., Kim, J., & Park, S. I. (2007). Involvement of TGF-beta1 signaling in cardiomyocyte differentiation from P19CL6 cells. Molecules and Cells, 24(3), 431-436.
117. Singla, D. K., & Sun, B. (2005). Transforming growth factor-beta2 enhances differentiation of cardiac myocytes from embryonic stem cells. Biochemical and biophysical research communications, 332(1), 135-141. doi:10.1016/j.bbrc.2005.04.098.
118. Li, T. S., Hamano, K., Nishida, M., et al. (2003). CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. American Journal of Physiology Heart and Circulatory Physiology, 285(3), H931-937.